Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Sarcoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Sarcoma

Cancer Family

Sarcoma

CI-CAN-00000344SARExplore in graph →

634 active trials17 approved drugs182 evidence items

NCIt: C9118
OncoTree: SARCNOS
DOID: 1115
MeSH: D012509
Other: 1 more code

Overview
Statistics
Survival
Genomics19
Variants & evidence182
Drugs37
Trials2686
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

2,686 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −13.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

StatusAll Active (any)Completed 1,192 Recruiting 463 Unknown 293 Terminated 293 Active Not Recruiting 200 Not Yet Recruiting 110 Withdrawn 93 Suspended 12 Enrolling By Invitation 10 No Longer Available 10 Available 8 Temporarily Not Available 1 Approved For Marketing 1

PhaseAll Early Phase 1 54 N/A 386 Phase 1 707 Phase 2 1,107 Phase 3 192 Phase 4 40

No study matches these filters